A securities class action has been filed against Microvast Holdings, Inc. on behalf of shareholders who purchased securities between April 1, 2025 and March 16, 2026, with a lead plaintiff deadline of September 21, 2026. The lawsuit alleges the company overstated its ability to meet high gross-margin targets and complete Huzhou Phase 3.2 by the end of 2025 while failing to disclose inventory management issues and customer platform rollout delays. On March 17, 2026, Microvast shares fell 34.2% to close at $1.52 after reporting fourth-quarter 2025 revenue of $96.5 million versus a $136.4 million consensus estimate, a gross margin of 1.0%, and a $32.5 million inventory impairment charge tied to specialized ESS components. The case was filed in the United States District Court for the Southern District of Texas, Houston Division. Institutional investors are advised to preserve trade records to assess potential losses.
Microvast Holdings IncSecurities class action alleges overstatement of gross-margin targets and Huzhou Phase 3.2 completion, with shares falling 34.2% after Q4 revenue miss and inventory impairment.